Alpha Paradigm Partners’s CRISPR Therapeutics CRSP Stock Holding History

Alpha Paradigm Partners’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$403K	Sell
2022 Q1	$1.28M	Buy